|
Transplantation
Citations 251-260 of 1455 total displayed.
|
Past content
(since Jan 1997):
|
Prevention of graft-versus-host disease by anti–IL-7R antibody
- Brile Chung, Eric P. Dudl, Dullei Min, Lora Barsky, Nancy Smiley, and Kenneth I. Weinberg
Blood 2007; 110: 2803-2810.
[Abstract]
[Full text]
[PDF]
Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease
- Claudio G. Brunstein, Juliet N. Barker, Daniel J. Weisdorf, Todd E. DeFor, Jeffrey S. Miller, Bruce R. Blazar, Philip B. McGlave, and John E. Wagner
Blood 2007; 110: 3064-3070.
[Abstract]
[Full text]
[PDF]
One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation
- Veronique Erard, Katherine A. Guthrie, Cara Varley, Judson Heugel, Anna Wald, Mary E. D. Flowers, Lawrence Corey, and Michael Boeckh
Blood 2007; 110: 3071-3077.
[Abstract]
[Full text]
[PDF]
G-CSF mobilizes slanDCs (6-sulfo LacNAc+ dendritic cells) with a high proinflammatory capacity
- Susanne H. C. Baumeister, Kristina Hölig, Martin Bornhäuser, Michael Meurer, E. Peter Rieber, and Knut Schäkel
Blood 2007; 110: 3078-3081.
[Abstract]
[Full text]
[PDF]
Donor-derived DNA in fingernails among recipients of allogeneic hematopoietic stem-cell transplants
- Daisuke Imanishi, Yasushi Miyazaki, Reishi Yamasaki, Yasushi Sawayama, Jun Taguchi, Hideki Tsushima, Takuya Fukushima, Shinichiro Yoshida, Hiroshi Sasaki, Tomoko Hata, and Masao Tomonaga
Blood 2007; 110: 2231-2234.
[Abstract]
[Full text]
[PDF]
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
- Christoph Kahl, Barry E. Storer, Brenda M. Sandmaier, Marco Mielcarek, Michael B. Maris, Karl G. Blume, Dietger Niederwieser, Thomas R. Chauncey, Stephen J. Forman, Edward Agura, Jose F. Leis, Benedetto Bruno, Amelia Langston, Michael A. Pulsipher, Peter A. McSweeney, James C. Wade, Elliot Epner, Finn Bo Petersen, Wolfgang A. Bethge, David G. Maloney, and Rainer Storb
Blood 2007; 110: 2744-2748.
[Abstract]
[Full text]
[PDF]
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease
- Françoise Bernaudin, Gérard Socie, Mathieu Kuentz, Sylvie Chevret, Michel Duval, Yves Bertrand, Jean-Pierre Vannier, Karima Yakouben, Isabelle Thuret, Pierre Bordigoni, Alain Fischer, Patrick Lutz, Jean-Louis Stephan, Nathalie Dhedin, Emmanuel Plouvier, Geneviève Margueritte, Dominique Bories, Suzanne Verlhac, Hélène Esperou, Lena Coic, Jean-Paul Vernant, and Eliane Gluckman, for the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
Blood 2007; 110: 2749-2756.
[Abstract]
[Full text]
[PDF]
Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia
- Daniele Lilleri, Giuseppe Gerna, Milena Furione, Maria Ester Bernardo, Giovanna Giorgiani, Stefania Telli, Fausto Baldanti, and Franco Locatelli
Blood 2007; 110: 2757-2760.
[Abstract]
[Full text]
[PDF]
Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone
- Jeffrey S. Miller, Daniel J. Weisdorf, Linda J. Burns, Arne Slungaard, John E. Wagner, Michael R. Verneris, Sarah Cooley, Rosanna Wangen, Susan K. Fautsch, Roby Nicklow, Todd DeFor, and Bruce R. Blazar
Blood 2007; 110: 2761-2763.
[Abstract]
[Full text]
[PDF]
Cotransplantation of ex vivo–expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation
- Lynne M. Ball, Maria Ester Bernardo, Helene Roelofs, Arjan Lankester, Angela Cometa, R. Maarten Egeler, Franco Locatelli, and Willem E. Fibbe
Blood 2007; 110: 2764-2767.
[Abstract]
[Full text]
[PDF]
|
|
